Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$548.35 - $738.84 $1.07 Million - $1.44 Million
-1,955 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$595.12 - $698.43 $1.16 Million - $1.37 Million
1,955 New
1,955 $1.37 Million
Q3 2021

Nov 12, 2021

SELL
$574.03 - $680.96 $28,701 - $34,048
-50 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$446.73 - $548.2 $22,336 - $27,410
50 New
50 $24,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Wealth Shield Partners, LLC Portfolio

Follow Wealth Shield Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Shield Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Shield Partners, LLC with notifications on news.